The University of Chicago Header Logo

Connection

Rex Haydon to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Rex Haydon has written about Dose-Response Relationship, Drug.
Rex Haydon
Connection Strength
0.078
Dose-Response Relationship, Drug
  1. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res. 2002 May; 8(5):1288-94.
    View in: PubMed
    Score: 0.035
  2. Adenovirus-mediated gene transfer in mesenchymal stem cells can be significantly enhanced by the cationic polymer polybrene. PLoS One. 2014; 9(3):e92908.
    View in: PubMed
    Score: 0.020
  3. Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation. 2009 Nov; 78(4):195-204.
    View in: PubMed
    Score: 0.014
  4. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.